Corporate Information

Nitto Denko Corporation


Nitto Denko is a $5.3 billion global technology company that has facilities in 43 countries and employs more than 18,000 employees, 1,800 of whom are in the U.S.

Nitto Denko has extensive expertise in polymers and adhesives. This focus has enabled them to be a pioneer and one of the largest manufacturers of transdermal drug delivery (TDD) systems in the world, and number one in Japan with three of the most successfully produced transdermal patches. These products have contributed immensely to their partners' businesses.

For more information on Nitto Denko Corporation click here, or for the Corporate Social Responsibility program click here.

 

Transdermal Patches Produced by Nitto Denko

Brand Name Drug Indications
Frandol Tape-S® Isosorbide Dinitrate Angina, Myocardial Infarction,
Coronary Artery Disease
Penles® Patch Lidocaine Pre-venous Cannulation (puncture)
Hokunalin Tape® Tulobuterol
 Asthma, Acute & Chronic Bronchitis,
Pulmonary Emphysema
                  

The work Nitto Denko has conducted on transdermal drug delivery systems has led to a number of awards:

  • 1993 Technology Prize of the Adhesive Society of Japan
  • 1998 Science and Technology Agency Director's Prize
  • 2001 PSJ Award for Drug Research and Development of the Pharmaceutical Society of Japan
The advancements in transdermal drug delivery systems haven't stopped there. Nitto Denko remains committed to leading the development of transdermal drug delivery technology and to continuing their contributions in the field of medical care to improve quality of life.

Nitto Denko routinely manufactures and markets niche-oriented products, with the focus on the synthesis, conversion and application of polymer materials and adhesive formulations for Functional, Electronic and Industrial products.


Click on the following links for more information:
©2004 Aveva Drug Delivery Systems. All rights reserved.